Trial Profile
F 18 T807 Tau PET Imaging of Frontotemporal Dementia
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 18 Mar 2024
Price :
$35
*
At a glance
- Drugs Flortaucipir-F-18 (Primary)
- Indications Alzheimer's disease; Dementia
- Focus Diagnostic use
- 22 Jan 2019 Planned End Date changed from 1 Sep 2020 to 1 Dec 2020.
- 22 Jan 2019 Planned primary completion date changed from 1 Mar 2020 to 1 Sep 2020.
- 19 Sep 2017 Status changed from not yet recruiting to withdrawn prior to enrolment.